Jul 17, 2026
GSK halts development of chronic cough drug after late-stage trial failures
GSK discontinued development of an experimental chronic cough treatment after it failed to meet key goals in two late-stage clinical trials, with the company stating it was unlikely to transform patient care. Shares fell about 4%.
2 sources
00